United States · FDA National Drug Code directory
Rylaze
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68727-900_cca29ff5-d000-43da-b64a-c65816a8a9c4
- Product NDC
- 68727-900
- Form
- INJECTION
- Composition / generic term
- asparaginase erwinia chrysanthemi (recombinant)-rywn
- Labeler
- Jazz Pharmaceuticals, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20210630
- Source listing expiry
- 20261231
Source-listed ingredients
- ASPARAGINASE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 3 VIAL, SINGLE-DOSE in 1 CARTON (68727-900-03) / .5 mL in 1 VIAL, SINGLE-DOSE (68727-900-01) · 68727-900-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →